{"id":2242,"date":"2022-01-04T00:00:00","date_gmt":"2022-01-04T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2242"},"modified":"2022-01-04T00:00:00","modified_gmt":"2022-01-04T00:00:00","slug":"centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/pl\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/","title":{"rendered":"Platforma CentoCloud\u00ae firmy CENTOGENE ma zrewolucjonizowa\u0107 diagnostyk\u0119 chor\u00f3b rzadkich dzi\u0119ki zdecentralizowanej platformie SaaS dla laboratori\u00f3w na ca\u0142ym \u015bwiecie"},"content":{"rendered":"<ul>\n<li>The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, interpret, and report genomic variants, and will be able to utilize the power of proprietary reagent kits CENTOGENE is developing in collaboration with Twist Bioscience for rare disease diagnostics<\/li>\n<li>CentoCloud provides rapid and reliable medical reports, which can be challenging for sequencing laboratories due to resource limitations as well as regulatory requirements<\/li>\n<li>Based on the decentralization of genetic testing and CENTOGENE\u2019s rare disease-centric Bio\/Databank and Artificial Intelligence (AI)-based clinical interpretation, CentoCloud will enable access to best-in-class medical reporting<\/li>\n<\/ul>\n<p>CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, January 04, 2022 (GLOBE NEWSWIRE \u2013 Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the global release of CentoCloud, a SaaS platform enabling decentralized analysis, interpretation, and reporting of genomic variants linked to rare diseases.<\/p>\n<p>Generating medical reports of diagnostic analyses is resource intensive \u2013 requiring an extensive amount of bioinformatic expertise, a sizeable databank of patient samples, and a streamlined recording system. Furthermore, as a trend, an increasing number of laboratories around the world are responding to regional requirements for increasing the amount of genetic sequencing being performed locally. CentoCloud, powered by proven bioinformatic pipelines and the world\u2019s largest Bio\/Databank of its kind, helps overcome these obstacles to make rare disease diagnostics accessible around the world.<\/p>\n<p>By providing a decentralized workflow, this fully digital solution aggregates Next Generation Sequencing (NGS) data from laboratories into the cloud, where automated, curated, bioinformatic analysis and AI-based genomic variant prioritization and classification generate high quality reporting of the utmost value. Additionally, the insights generated from consented data via CentoCloud will augment the Bio\/Databank and may contribute to the discovery and development of novel therapeutics to treat rare diseases in the future.<\/p>\n<p>\u201cAt CENTOGENE, we are committed to continuing to expand our footprint to enable access to genetic testing for rare diseases anywhere in the world,\u201d said Dr. Maximilian Schmid, CENTOGENE\u2019s Chief Commercial Officer &#8211; Diagnostics. \u201cTaking CentoCloud from a proof-of-concept to a commercialized service, labs around the world now have direct access to straightforward implementation of NGS and can deliver timely results to combat rare diseases, no matter where they are found.\u201d<\/p>\n<h2 class=\"h3\">CentoCloud \u2013 The End-to-End Decentralized Diagnostic Solution<\/h2>\n<p>The digital bioinformatics solution offers several key features that advance rare disease patient care:<\/p>\n<h4>Accessibility<\/h4>\n<ul>\n<li>CentoCloud has been designed to complement the large existing base of state-of-the-art Illumina sequencing analyzer technology products around the world. In addition, earlier this year CENTOGENE announced a collaboration with Twist Bioscience to leverage their expertise in genetic kit development. Laboratories taking advantage of the CentoCloud SaaS platform benefit from higher diagnostic yields and a faster time to diagnosis at lower overall costs<\/li>\n<\/ul>\n<h4>Automation<\/h4>\n<ul>\n<li>The automated bioinformatics pipeline analyzes NGS data based on CENTOGENE&#8217;s validated testing products, annotated with data from the Company\u2019s proprietary rare disease-centric Bio\/Databank<\/li>\n<\/ul>\n<h4>Accuracy<\/h4>\n<ul>\n<li>Drawing on more than 15 years of rare disease diagnostic experience and AI-supported clinical interpretation and medical reporting, CentoCloud facilitates the same high quality and diagnostic accuracy as CENTOGENE\u2019s offers in its own certified state-of-the-art labs<\/li>\n<\/ul>\n<p>For further information about CentoCloud, visit: <a href=\"https:\/\/www.centogene.com\/pl\/diagnostyka\/centocloud-bioinformatics-solution.html\/\">https:\/\/www.centogene.com\/diagnostics\/centocloud-bioinformatics-solution.html<\/a><\/p>\n<p>This cloud-based SaaS solution represents another significant step forward for CENTOGENE\u2019s mission to increase its diagnostic footprint and enable the cure of 100 rare diseases within the next 10 years. To learn more, visit: <a href=\"https:\/\/www.centogene.com\/pl\/virtual-investor-event\/\">https:\/\/www.centogene.com\/virtual-investor-event<\/a><\/p>\n<h4>O firmie CENTOGENE<\/h4>\n<p>CENTOGENE zajmuje si\u0119 diagnostyk\u0105 i badaniami nad chorobami rzadkimi, przekszta\u0142caj\u0105c rzeczywiste dane kliniczne, genetyczne i multiomiczne w celu diagnozowania, zrozumienia i leczenia chor\u00f3b rzadkich. Naszym celem jest racjonalizacja decyzji terapeutycznych i przyspieszenie rozwoju nowych lek\u00f3w sierocych poprzez wykorzystanie naszej rozleg\u0142ej wiedzy i danych na temat chor\u00f3b rzadkich. CENTOGENE opracowa\u0142o globaln\u0105, autorsk\u0105 platform\u0119 bada\u0144 nad chorobami rzadkimi, opart\u0105 na naszym repozytorium danych dotycz\u0105cych ponad 600 000 pacjent\u00f3w z ponad 120 kraj\u00f3w.<\/p>\n<p>Platforma firmy obejmuje dane epidemiologiczne, fenotypowe i genetyczne, kt\u00f3re odzwierciedlaj\u0105 globaln\u0105 populacj\u0119, a tak\u017ce biobank pr\u00f3bek krwi pacjent\u00f3w i kultur kom\u00f3rkowych. CENTOGENE uwa\u017ca, \u017ce jest to jedyna platforma skoncentrowana na kompleksowej analizie danych wielopoziomowych w celu lepszego zrozumienia rzadkich chor\u00f3b dziedzicznych. Umo\u017cliwia ona lepsz\u0105 identyfikacj\u0119 i stratyfikacj\u0119 pacjent\u00f3w oraz ich chor\u00f3b podstawowych, co umo\u017cliwia i przyspiesza odkrywanie, rozw\u00f3j i dost\u0119p do lek\u00f3w sierocych. Na dzie\u0144 31 grudnia 2020 r. firma wsp\u00f3\u0142pracowa\u0142a z ponad 30 partnerami farmaceutycznymi.<\/p>\n<p>Obserwuj nas na <a href=\"https:\/\/de.linkedin.com\/company\/centogene\" target=\"_blank\" title=\"Link do LinkedIn\">LinkedIn<\/a><\/p>\n<h4>O\u015bwiadczenia prognostyczne<\/h4>\n<p>Niniejsza informacja prasowa zawiera \u201co\u015bwiadczenia prognostyczne\u201d w rozumieniu federalnych przepis\u00f3w dotycz\u0105cych papier\u00f3w warto\u015bciowych w Stanach Zjednoczonych. Zawarte w niej o\u015bwiadczenia, kt\u00f3re nie maj\u0105 jednoznacznie historycznego charakteru, maj\u0105 charakter prognostyczny, a s\u0142owa \u201cprzewidywa\u0107\u201d, \u201cwierzy\u0107\u201d, \u201ckontynuowa\u0107\u201d, \u201coczekiwa\u0107\u201d, \u201cszacowa\u0107\u201d, \u201czamierza\u0107\u201d, \u201cprognozowa\u0107\u201d oraz podobne wyra\u017cenia i czasowniki w czasie przysz\u0142ym lub warunkowym, takie jak \u201cb\u0119dzie\u201d, \u201cby\u0142by\u201d, \u201cpowinien\u201d, \u201cm\u00f3g\u0142by\u201d, \u201cmo\u017ce\u201d, \u201cmo\u017ce\u201d i \u201cmo\u017ce\u201d, maj\u0105 na celu identyfikacj\u0119 o\u015bwiadcze\u0144 prognostycznych. Takie o\u015bwiadczenia prognostyczne wi\u0105\u017c\u0105 si\u0119 ze znanymi i nieznanymi ryzykami, niepewno\u015bciami i innymi istotnymi czynnikami, kt\u00f3re mog\u0105 spowodowa\u0107, \u017ce rzeczywiste wyniki, efektywno\u015b\u0107 lub osi\u0105gni\u0119cia CENTOGENE b\u0119d\u0105 istotnie r\u00f3\u017cni\u0107 si\u0119 od jakichkolwiek przysz\u0142ych wynik\u00f3w, efektywno\u015bci lub osi\u0105gni\u0119\u0107 wyra\u017conych lub dorozumianych w o\u015bwiadczeniach prognostycznych. Takie ryzyka i niepewno\u015bci obejmuj\u0105 mi\u0119dzy innymi negatywne warunki gospodarcze na ca\u0142ym \u015bwiecie oraz ci\u0105g\u0142\u0105 niestabilno\u015b\u0107 i zmienno\u015b\u0107 na \u015bwiatowych rynkach finansowych, wp\u0142yw pandemii COVID-19 na nasz\u0105 dzia\u0142alno\u015b\u0107 i wyniki operacyjne, mo\u017cliwe zmiany w obowi\u0105zuj\u0105cych i proponowanych przepisach, regulacjach i politykach rz\u0105dowych, presj\u0119 wynikaj\u0105c\u0105 ze wzrostu konkurencji i konsolidacji w naszej bran\u017cy, koszty i niepewno\u015b\u0107 zwi\u0105zan\u0105 z zatwierdzeniem regulacyjnym, w tym przez Ameryka\u0144sk\u0105 Agencj\u0119 ds. \u017bywno\u015bci i Lek\u00f3w, nasze uzale\u017cnienie od stron trzecich i partner\u00f3w, w tym nasz\u0105 zdolno\u015b\u0107 do zarz\u0105dzania wzrostem i nawi\u0105zywania nowych relacji z klientami, nasz\u0105 zale\u017cno\u015b\u0107 od bran\u017cy chor\u00f3b rzadkich, nasz\u0105 zdolno\u015b\u0107 do zarz\u0105dzania ekspansj\u0105 mi\u0119dzynarodow\u0105, nasz\u0105 zale\u017cno\u015b\u0107 od kluczowego personelu, nasz\u0105 zale\u017cno\u015b\u0107 od ochrony w\u0142asno\u015bci intelektualnej, wahania naszych wynik\u00f3w operacyjnych spowodowane wp\u0142ywem kurs\u00f3w walutowych, nasz\u0105 zdolno\u015b\u0107 do usprawnienia wykorzystania got\u00f3wki, nasze zapotrzebowanie na dodatkowe finansowanie i nasz\u0105 zdolno\u015b\u0107 do kontynuowania dzia\u0142alno\u015bci lub inne czynniki. Aby uzyska\u0107 wi\u0119cej informacji na temat ryzyka i niepewno\u015bci, kt\u00f3re mog\u0105 spowodowa\u0107, \u017ce rzeczywiste wyniki b\u0119d\u0105 si\u0119 r\u00f3\u017cni\u0107 od tych wyra\u017conych w niniejszych o\u015bwiadczeniach prognostycznych, a tak\u017ce ryzyka zwi\u0105zanego z dzia\u0142alno\u015bci\u0105 CENTOGENE og\u00f3lnie, zapoznaj si\u0119 z czynnikami ryzyka CENTOGENE przedstawionymi w formularzu 20-F z\u0142o\u017conym przez CENTOGENE 15 kwietnia 2021 r. w Komisji Papier\u00f3w Warto\u015bciowych i Gie\u0142d (SEC) oraz w p\u00f3\u017aniejszych dokumentach z\u0142o\u017conych w SEC. Wszelkie o\u015bwiadczenia prognostyczne zawarte w niniejszym komunikacie prasowym obowi\u0105zuj\u0105 wy\u0142\u0105cznie na dzie\u0144 jego sporz\u0105dzenia, a CENTOGENE wyra\u017anie zrzeka si\u0119 obowi\u0105zku aktualizacji jakichkolwiek o\u015bwiadcze\u0144 prognostycznych, niezale\u017cnie od tego, czy wynika to z nowych informacji, przysz\u0142ych zdarze\u0144, czy z innych przyczyn.<\/p>\n<h5>Kontakt dla medi\u00f3w: &nbsp;<\/h5>\n<p>CENTOGENE<br \/> Ben Legg<br \/> Komunikacja korporacyjna&nbsp;<br \/> <a href=\"mailto:press@centogene.com\" title=\"Napisz e-mail\">press(at)centogene(dot)com<\/a><\/p>\n<p>Lennart Streibel<br \/> Relacje inwestorskie<br \/> <a href=\"mailto:investor.relations@centogene.com\u00a0\" title=\"Napisz e-mail\">investor.relations(at)centogene(dot)com&nbsp;<\/a><\/p>\n<p>Stern IR &nbsp;<br \/> Brendan Payne<br \/> +1 (212) 698 8695<br \/> <a href=\"mailto:brendan.payne@sternir.com\" title=\"Napisz e-mail\">brendan.payne(at)sternir(dot)com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2242","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/pl\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/pl\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-04T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisane przez\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World\",\"datePublished\":\"2022-01-04T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\\\/\"},\"wordCount\":1150,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\\\/\",\"name\":\"CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2022-01-04T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\\\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/pl\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/pl\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/","og_locale":"pl_PL","og_type":"article","og_title":"CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World | CENTOGENE","og_description":"The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, [&hellip;]","og_url":"https:\/\/www.centogene.com\/pl\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/","og_site_name":"CENTOGENE","article_published_time":"2022-01-04T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Napisane przez":"admincg","Szacowany czas czytania":"6 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World","datePublished":"2022-01-04T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/"},"wordCount":1150,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"pl-PL","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/","url":"https:\/\/www.centogene.com\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/","name":"CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2022-01-04T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogenes-centocloudr-set-to-revolutionize-rare-disease-diagnostics-with-decentralized-saas-platform-for-laboratories-around-the-world\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE\u2019s CentoCloud\u00ae Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Kierowanie medycyn\u0105 precyzyjn\u0105","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"admincg","url":"https:\/\/www.centogene.com\/pl\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/posts\/2242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/comments?post=2242"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/posts\/2242\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/media?parent=2242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/categories?post=2242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/tags?post=2242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}